We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Columvi Roche Products Pty Ltd
Product name
Columvi
Sponsor
Accepted date
Sep-2024
Active ingredients
glofitamab
Proposed indication
For the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.
Application type
C (new indication)
Publication date
Sep-2024